The role of low dose intrathecal infusion
Dr. Anjum Bux presents the role of low-dose intrathecal infusions. He presents the history and evolution of the therapy and discusses two studies by Dr. Grider, who promoted the idea of low-dose infusions and intrathecal therapy. Dr. Bux shares a study by Dr. Hamza and includes practice considerations and anecdotes from private practitioners, such as Dr. David Caraway. Dr. Bux combines the evidence from practice in his approach to low-dose protocols and provides recommendations on factors to consider when treating patients with low-dose intrathecal infusions.
This experience is powered by CMEfy – an AI-powered platform that directs learners along a pathway to capture reflections at point of inspiration, point of care. Clinicians may earn CME/CE credit via ReflectCE, the accredited activity portal. Learn more at about.cmefy.com/cme-info
Comment
expand_more
expand_less